Stimulation of hypothalamic histidine decarboxylase by calcium-calmodulin and protein kinase (cAMP-dependent) inhibitor
✍ Scribed by Z. Huszti; K. Magyar
- Publisher
- SP Birkhäuser Verlag Basel
- Year
- 1987
- Tongue
- English
- Weight
- 230 KB
- Volume
- 20
- Category
- Article
- ISSN
- 1420-908X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Galantamine, a novel Alzheimer's drug, is known to inhibit acetylcholinesterase activity and potentiate nicotinic acetylcholine receptor (nAChR) in the brain. We previously reported that galantamine potentiates the NMDA‐induced currents in primary cultured rat cortical neurons. We now s
## B i k n g h a m , Alabama - The effects of CAMP-dependent protein kinase (CAMP-PK) and CaZf/calmodulin-dependent protein kinase I1 (CaMKII) phosphorylation on the calpainmediated degradation of microtubule-associated protein 2 (MAP-2) were studied. Both CAMP-PK and CaMKII readily phosphorylated
Previous studies have shown that activators of protein kinase C (C kinase) produce synaptic potentiation in the hippocampus. For example, the C kinase activator phorbol dibutyrate has been shown to increase transmitter release in the hippocampus. In addition, a role for C kinase in long-term potenti